About Human Metabotropic Glutamate Receptor 4 (GRM4/mGluR4) Stable Cell Line

Metabotropic Glutamate Receptor 4 (GRM4), commonly known as mGluR4, is a Class C G protein-coupled receptor (GPCR) belonging to the group III metabotropic glutamate receptor family, which also includes mGluR6, mGluR7, and mGluR8. GRM4 is activated by the neurotransmitter glutamate and functions primarily as a presynaptic inhibitory receptor that modulates neurotransmitter release and neuronal excitability. Upon activation, GRM4 predominantly couples to Gi/o proteins, resulting in inhibition of adenylate cyclase activity, decreased intracellular cAMP levels, modulation of ion channel function, and suppression of excitatory neurotransmission.

GRM4 is widely expressed throughout the central nervous system, particularly in the cerebellum, basal ganglia, hippocampus, thalamus, olfactory bulb, and other brain regions involved in motor control, cognition, sensory processing, and synaptic plasticity. By regulating glutamate release at synapses, GRM4 helps maintain excitatory-inhibitory balance and protects neurons from excessive excitatory signaling. Dysregulation of GRM4 signaling has been implicated in Parkinson's disease, anxiety disorders, chronic pain, epilepsy, neuroinflammatory conditions, and other neurological disorders. As a result, GRM4 has emerged as an attractive therapeutic target for neurodegenerative and neuropsychiatric disease research.

eEnzyme's Human GRM4 Stable Cell Line provides a reliable and reproducible cellular platform for investigating mGluR4-mediated signaling pathways and evaluating receptor-targeted therapeutics. The cell line enables quantitative assessment of agonists, antagonists, positive allosteric modulators (PAMs), negative allosteric modulators (NAMs), and novel glutamatergic compounds through cAMP assays, reporter gene assays, and other GPCR functional screening platforms. Researchers can utilize this stable cell line for receptor characterization, ligand profiling, potency determination, lead optimization, and high-throughput screening applications supporting neuroscience and central nervous system drug discovery programs.

Applications of the GRM4 Stable Cell Line

• GRM4 (mGluR4) receptor pharmacology studies
• Glutamate signaling investigations
• Agonist, antagonist, PAM, and NAM screening
• Parkinson's disease research
• Neurodegenerative disease studies
• Anxiety and pain pathway investigations
• cAMP and GPCR functional assays
• High-throughput screening applications

Biological Significance of GRM4

GRM4 is an important regulator of glutamatergic neurotransmission and neuronal circuit activity. Activation of mGluR4 suppresses presynaptic neurotransmitter release and helps maintain synaptic homeostasis within the central nervous system. In the basal ganglia, GRM4 signaling has attracted considerable attention as a potential therapeutic mechanism for Parkinson's disease due to its ability to modulate motor control pathways. The receptor also plays roles in neuroprotection, inflammation regulation, pain processing, and sensory signaling. Emerging evidence suggests that GRM4 may influence immune cell function and neuroinflammatory responses, further expanding its therapeutic relevance beyond traditional neuroscience applications. Because of its involvement in regulating excitatory neurotransmission and neuronal health, GRM4 remains an important target for neurological disease research and GPCR-focused drug discovery. The GRM4 Stable Cell Line provides a valuable tool for studying glutamate receptor biology and advancing the development of next-generation therapeutics targeting neurodegenerative and neuropsychiatric disorders.